Atherogenic Dyslipidemia
📧 Sign up to get email alerts when something new happens for Atherogenic Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females [Phase 4]
Phase 4 clinical trial updating the use of extended-release niacin and fenofibrate for atherogenic dyslipidemia in obese females; study comp…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Resistant Starch Insulin Sensitivity Trial [NA]
A completed trial evaluating whether resistant starch improves insulin sensitivity in healthy individuals and in those with cardiovascular r…
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity [Phase 2]
Phase 2 pilot study update of Genfit's GFT505 (elafibranor) in patients with atherogenic dyslipidemia and abdominal obesity; the trial has c…